Xa ufumene i- Hodgkin lymphoma , ingxelo ye-biopsy ingabonisa uhlobo lwe-Hodgkin lymphoma eyenziwe. Kukho iintlanu eziphambili zeHodgkin lymphoma. Ahluke kuye kuye, njani amalungu omzimba angasichaphazelekayo, kwaye kwinqanaba elithatyathwa ngalo.
Ingaba unyango lweHodgkin Lymphoma uxhomekeke kwiNdidi yezifo?
Ngokuqhelekileyo, uhlobo oluthile aluyi kutshintsha ukhetho lwonyango.
Ukunyangwa kwesifo seHodgkin kuxhomekeka ngokubanzi malunga nokubandakanyeka (kwinqanaba) kwaye kungekhona uhlobo lwesifo. Kweemeko ezithile, ke, uhlobo lwesifo lunokuqikelela ukuba amathuba eendawo ezithile zomzimba zichaphazeleka kwaye zingachaphazela ukhetho lwabagqirha lwezonyango. Ukuba unemibuzo malunga neendlela zokuxilonga kunye nokonyango, baxoxe nabo kunye neqela lakho lononophelo lwezempilo ukuze uwaqonde ukuba uneliseko.
I-Nodular Sclerosing iHodgkin Lymphoma (NSHL)
Olu luhlobo oluqhelekileyo lweHodgkin lymphoma. Kwamazwe athuthukile 60-80% abantu abachaphazelekayo yi-Hodgkin isifo seNodular Sclerosing subtype. Kuqhelekileyo kubasetyhini kwaye kakhulu kuthinta abantu abatsha-abatsha kunye nabantu abadala. Esi sifo sithintela kakhulu iisalathisi entanyeni okanye emagqabini, okanye ngaphakathi kwesifuba.
I-Mixed Cellularity iHodgkin Lymphoma (MCHL)
Olu lunye uhlobo oluqhelekileyo lwe-Hodgkin lymphoma, kunye ne-15-30% yalabo bafunyanisiweyo baye baxuba izifo zeselula.
Olu hlobo luqhelekileyo kumazwe asakhulayo. Abantu abanaluphi na ubudala banokuchaphazeleka. Amadoda nabasetyhini bachaphazeleka ngokufanayo. Olu hlobo lwesifo luyakwazi ukubandakanya isisu esisetyenziselwa iindidi ze-sclerosing eziqhelekileyo, kwaye kungenakwenzeka ukuba zibandakanye iinombolo ngaphakathi kwesifuba.
I-Lymphocyte iphelile iHodgkin Lymphoma (LDHL)
I-subtype yokunciphisa i-lymphocyte yinto engavumelekanga ye-Hodgkin lymphoma eyenza kuphela i-1% yabantu abachaphazelekayo ngesifo.
Kubonakala kubantu asebekhulile kwaye ngokuqhelekileyo kufunyaniswa kwisigaba esiphambili xa i-lymphoma ihlasele izitho ezahlukeneyo zomzimba. Kuqheleke kakhulu kulabo abane- HIV abanentsholongwane . Ingabonakala kwisisu, isitha, isibindi kunye nomnatha wethambo.
I-Lymphocyte ecebileyo yeHolgkin Lymphoma (LRCHL)
Le yinye i-subtype engaqhelekanga eyenza malunga ne-5-6% yezigulane ze-Hodgkin. Idla ngokuphindaphindiweyo kubesilisa kwaye ichaphazela abantu ngokuqhelekileyo kwiminyaka yabo yesithathu okanye ama-forties. Uninzi lwabantu lufunyaniswa kwiindlela zokuqala kunye nokuphendula unyango luhle kakhulu. Akunakwenzeka ukuba kufumaneke kwii-lymph nodes ezimbalwa kwaye kwenzeka kwisiqingatha esiphezulu somzimba.
I-Lymphocyte yeNodular Predominant Hodgkin Lymphoma (NLPHL)
Olu hlobo luthiwa luhlobo olukhethekileyo lwe-Hodgkin isifo ehlukileyo kwezinye iindidi ezikhankanywe ngasentla, oku kuhluka ku-4-5% kuwo onke amacala e-Hodgkin. Ngokutsho kwezilwanyana-pathologists olu hlobo lufana no-Non-Hodgkin lymphoma (NHL). Kuzo zonke iinkalo zonyango, nangona kunjalo, ezi zinto zifana nelo lucphocytes-rich riches of Hodgkin lymphoma. Uninzi lwabantu luyavavanywa kwangethuba kwaye luyenzi kakuhle emva kokonyango.
Umthombo:
Iyintoni isifo seHodgkin? American Cancer Society, 02/09/2016